Remove 2013 Remove Access Remove Programs Remove Treatment
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. In 2013, section C and J of Canada’s FDR statute were amended so that “restricted drugs” were inaccessible through SAP.

Therapy 52
article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

A regulatory framework for medical cannabis was first implemented in 2013 when Uruguay pioneered and paved the way through to legalization. Patients, and their treatment, therefore, are the priority. Treatment options may be limited by government-approved imports, a practitioner’s prescription or pharmacy stock.

Access 89
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Canada: Regulatory Amendments Authorize Requests For Psychedelic Restricted Drugs

Cannabis Law Report

Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient. Footnotes.

Access 52
article thumbnail

Canada: First patient in Quebec gets approval for magic mushroom therapy

Cannabis Law Report

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52
article thumbnail

Jersey Clobbers “Cannabis Licensing Lawsuits” and launches Triumphant Adult Use Program – Cannabis Business Executive

SpeedWeed

With the Eastern seaboard’s most ambitious Adult Use program primed to explode, New Jersey’s Superior Court Appellate Division (“Appellate Division”) just lifted its “stay” on scoring 18 month old Medical Marijuana applications clearing the way for 5 cultivation, 15 dispensary, and 4 vertically integrated license awards. 24:6I Et Seq.

article thumbnail

Illinois Governor Signs Bill Expanding Medical Marijuana Program

The Joint Blog

Pritzker signed two measure that expands the state’s medical-marijuana program while cementing it into law. Effective immediately, nurse practitioners and physicians’ assistants will be able to certify patients for inclusion in the program.” ” The two measures signed into law are Senate Bill 2023 and Senate Bill 455.

article thumbnail

DMT Therapy: Coming to a Clinic Near You?

Canna Law Blog

Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction. MDMA (Ecstasy) Nears FDA Approval for PTSD Treatment.

Therapy 88